These effects may relate to the protective effect of HMGCR inhibitors, as it found that male infertility patients typically had elevated levels of certain inflammatory markers, such as C-reactive protein, interleukin-6, and tumor necrosis factor-α. The gene discussed is CRP; the disease is male infertility.